Skip to main content

We’ve updated our Terms & Conditions and Privacy Policy. By using this site, you agree to these terms.


FORTY FORT, PA -- Two Geisinger Health System researchers have been invited to participate in the prestigious 2015 FH (familial hypercholesterolemia) Foundation Global Summit, Sept. 24-25, in Pasadena, Calif. The annual invitation-only event is dedicated to the science and treatment of FH.

Michael Murray (left), M.D., director of clinical genomics in Geisinger’s Genomic Medicine Institute, and Caroline Graham (right), CRNP, advanced practice provider in the Richard & Marion Pearsall Heart Hospital at Geisinger Wyoming Valley Medical Center, have been invited. Dr. Murray will participate in an experts’ debate on how to find and manage FH patients at a healthcare system level.

Familial hypercholesterolemia is a largely underdiagnosed, life threatening and treatable genetic disorder that can cause heart attack and stroke at an early age.

The annual invitation-only summit is a global gathering of medical experts, patient advocacy organizations, health care providers and individuals with FH. The two-day event features presentations that provide a platform to share insights and practices for improved awareness, diagnosis and treatment of FH.

This year’s theme, “FH at the Crossroads: New Data on Prevalence & Novel Strategies for Prevention,” will cover a wide variety of topics and solutions, including insights into the prevalence and characteristics of the FH population, optimizing patient care and engagement, and strategies for early diagnosis and prevention.

“The FH Global Summit is a phenomenal opportunity for the Geisinger Health System and the Pearsall Heart Hospital,” Graham said. “Ultimately, this will benefit my patients and the patients I will soon meet.”

Geisinger’s GenomeFIRST program is expected to deliver results back to several hundred patients with FH over the next two years and will help build new models for diagnosis and treatment of this life-threatening disease. Dr. Murray and NP Graham were among the faculty that highlighted this plan in Geisinger’s inaugural GenomeFIRST symposium, “Changing the Lives of Patients with Familial Hypercholesterolemia,” which was held in May.

About Geisinger
Geisinger is committed to making better health easier for the more than 1 million people it serves. Founded more than 100 years ago by Abigail Geisinger, the system now includes 10 hospital campuses, a health plan with more than half a million members, a research institute and the Geisinger College of Health Sciences, which includes schools of medicine, nursing and graduate education. With more than 25,000 employees and 1,700+ employed physicians, Geisinger boosts its hometown economies in Pennsylvania by billions of dollars annually. Learn more at or connect with us on Facebook, Instagram, LinkedIn and Twitter.

Content from General Links with modal content